Condition: Polycystic Ovarian Syndrome (PCOS) · Sponsor: University Hospital Erlangen
The purpose of the study is to validate recently identified biomarkers for the identification of PCOS in adolecent and young adult women.
This description comes directly from the study's public registry record.
Laura Lotz, Dr. med. · +49 9131 85 44023 · laura.lotz@uk-erlangen.de
Ralf Dittrich, Prof. · ralf.dittrich@uk-erlangen.de
Always discuss trial participation with your own doctor first.
| Department of Obstetrics and Gynecology, University Erlangen Hospital, Friedrich Alexander University of Erlangen-Nuremberg, Erlangen, Germany | Erlangen, Germany | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06642831